EUVIMEDEUVIMED entdecken
Historischer BeitragÜbersichtsarbeit

The antiseptic Miramistin: a review of its comparative in vitro and clinical activity

Ali Osmanov, Zara Farooq, Malcolm D Richardson, David W Denning

FEMS Microbiology Reviews · 01.07.2020 · 44 (4) · 399-417

DOI: 10.1093/femsre/fuaa012 ↗

Kurz gefasst

Historischer Beitrag in der Zeitschrift FEMS Microbiology Reviews, online erschienen am 09.05.2020. Verfasst von Ali Osmanov und 3 weiteren Autor:innen. Beteiligte Einrichtung: Next Level Diagnostics, Mikhailovsky lane 20,7, Kiev 01001, Ukraine. Hauptthemen laut MEDLINE: Benzalkonium Compounds. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 154 Literaturangaben. Gefördert von: funding agencies in the public, commercial.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Miramistin is a topical antiseptic with broad antimicrobial action, including activity against biofilms and a clinical profile showing good tolerability. Miramistin was developed within a framework of the Soviet Union Cold War Space Program. It is available for clinical use in several prior Soviet bloc countries, but barely known outside of these countries and there is almost no mention of miramistin in the English literature. However, considering emerging antimicrobial resistance, the significant potential of miramistin justifies its re-evaluation for use in other geographical areas and conditions. The review consists of two parts: (i) a review of the existing literature on miramistin in English, Russian and Ukrainian languages; (ii) a summary of most commonly used antiseptics as comparators of miramistin. The oral LD50 was 1200 mg/kg, 1000 mg/kg and 100 g/L in rats, mice and fish, respectively. Based on the results of the review, we suggest possible applications of miramistin and potential benefits over currently used agents. Miramistin offers a novel, low toxicity antiseptic with many potential clinical uses that need better study which could address some of the negative impact of antimicrobial, antiseptic and disinfectant resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Benzalkonium CompoundsAnimalsAnti-Infective AgentsAnti-Infective Agents, LocalCell SurvivalHistory, 20th CenturyLethal Dose 50RussiaUSSR

Stichwörter der Autor:innen

CandidaMRSAantimicrobial resistancemiramistintoxicity

Substanzen

Anti-Infective AgentsAnti-Infective Agents, LocalBenzalkonium Compoundsmiramistin

Autor:innen und Institutionen

  • Next Level Diagnostics, Mikhailovsky lane 20,7, Kiev 01001, Ukraine.
  • School of Biological and Chemical Sciences, Queen Mary University of London, Mile End Road, London E1 4NS, UK.
  • Mycology Reference Centre Manchester, University Hospital of South Manchester, Manchester University NHS Foundation Trust, Manchester M23 9LT, UK.
  • Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
  • National Aspergillosis Centre, University Hospital of South Manchester, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Wythenshawe Hospital Southmoor Road, Wythenshawe, Manchester…

Förderung

  • funding agencies in the public, commercial

Zitieren

APA

Osmanov, A., Farooq, Z., Richardson, M. D., & Denning, D. W. (2020). The antiseptic Miramistin: a review of its comparative in vitro and clinical activity. FEMS Microbiology Reviews, 44(4), 399-417. https://doi.org/10.1093/femsre/fuaa012

Vancouver

Osmanov A, Farooq Z, Richardson MD, Denning DW. The antiseptic Miramistin: a review of its comparative in vitro and clinical activity. FEMS Microbiology Reviews. 2020;44(4):399-417. doi:10.1093/femsre/fuaa012

BibTeX
@article{Osmanov2020,
  author = {Osmanov, Ali and Farooq, Zara and Richardson, Malcolm D and Denning, David W},
  title = {The antiseptic Miramistin: a review of its comparative in vitro and clinical activity},
  journal = {FEMS Microbiology Reviews},
  year = {2020},
  volume = {44},
  number = {4},
  pages = {399--417},
  doi = {10.1093/femsre/fuaa012}
}
Kostenlos starten →